Cargando…

Is Metabolic Rate Increased in Insomnia Disorder? A Systematic Review

Background: Insomnia disorder is a highly prevalent health condition, affecting ~10–15% of the adult population worldwide. A central feature of insomnia is hyperarousal characterized as persistent and increased somatic, cognitive and cortical stimulation. Hyperarousal leads to a state of conditioned...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chapman, Julia L., Comas, Maria, Hoyos, Camilla M., Bartlett, Delwyn J., Grunstein, Ronald R., Gordon, Christopher J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054926/ https://www.ncbi.nlm.nih.gov/pubmed/30061861 http://dx.doi.org/10.3389/fendo.2018.00374

Ejemplares similares

The Relationship between Anxiety, Subjective and Objective Sleep, Chronotype and Circadian Rhythms with Depressive Symptoms in Insomnia Disorder
por: Comas, Maria, et al.
Publicado: (2023)

Acceptability, tolerability, and potential efficacy of cognitive behavioural therapy for Insomnia Disorder subtypes defined by polysomnography: A retrospective cohort study
por: Miller, Christopher B., et al.
Publicado: (2018)

A review of psychosocial factors and personality in the treatment of obstructive sleep apnoea
por: Cayanan, Elizabeth A., et al.
Publicado: (2019)

Cannabidiol (CBD) and Δ(9)-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial
por: Suraev, Anastasia, et al.
Publicado: (2020)

Physiological Markers of Arousal Change with Psychological Treatment for Insomnia: A Preliminary Investigation
por: Miller, Christopher B., et al.
Publicado: (2015)

Detecting insomnia in patients with low back pain: accuracy of four self-report sleep measures
por: Alsaadi, Saad M, et al.
Publicado: (2013)

Insomnia subtypes characterised by objective sleep duration and NREM spectral power and the effect of acute sleep restriction: an exploratory analysis
por: Kao, Chien-Hui, et al.
Publicado: (2021)

Framework for the Design Engineering and Clinical Implementation and Evaluation of mHealth Apps for Sleep Disturbance: Systematic Review
por: Aji, Melissa, et al.
Publicado: (2021)

The Effect of Light Therapy on Electroencephalographic Sleep in Sleep and Circadian Rhythm Disorders: A Scoping Review
por: Pun, Teha B., et al.
Publicado: (2022)

Impaired Neurobehavioural Performance in Untreated Obstructive Sleep Apnea Patients Using a Novel Standardised Test Battery
por: D'Rozario, Angela L., et al.
Publicado: (2018)

People with insomnia: experiences with sedative hypnotics and risk perception
por: Cheung, Janet M. Y., et al.
Publicado: (2015)

Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder (‘CUPID’ study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial
por: Lavender, Isobel, et al.
Publicado: (2023)

Editorial: Metabolic Health in Normal and Abnormal Sleep
por: Kim, David, et al.
Publicado: (2020)

O006 Acute effects of combined cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC) in insomnia disorder: A randomised, placebo-controlled trial using high-density EEG
por: Suraev, A, et al.
Publicado: (2022)

Improvements in cognitive function and quantitative sleep electroencephalogram in obstructive sleep apnea after six months of continuous positive airway pressure treatment
por: D’Rozario, Angela L, et al.
Publicado: (2022)

O028 Effectiveness of digital brief behavioural therapy for insomnia with wearable technology: pilot randomized controlled trial
por: Gordon, C, et al.
Publicado: (2021)

P114 The effect of light interventions on sleep macro- and micro-architecture in sleep and circadian rhythm disorders: A scoping review
por: Pun, T, et al.
Publicado: (2021)

Homeostatic glucocorticoid signaling in airway smooth muscle: A roadmap to asthma pathogenesis
por: Grunstein, Michael M.
Publicado: (2023)

Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults
por: Tuft, Colin, et al.
Publicado: (2023)

Open-label placebo for insomnia (OPIN): study protocol for a cohort multiple randomised controlled trial
por: Colagiuri, Ben, et al.
Publicado: (2021)

Embedding digital sleep health into primary care practice: A triangulation of perspectives from general practitioners, nurses, and pharmacists
por: Cheung, Janet MY, et al.
Publicado: (2023)

Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial
por: Sletten, Tracey L., et al.
Publicado: (2018)

Light-based methods for predicting circadian phase in delayed sleep–wake phase disorder
por: Murray, Jade M., et al.
Publicado: (2021)

P057 Exploring the ‘Pharmacist Role’ in Insomnia Management and Care Provision: A Scoping Review
por: Basheti, M, et al.
Publicado: (2023)

Adolescent Sleep Patterns and Night-Time Technology Use: Results of the Australian Broadcasting Corporation's Big Sleep Survey
por: Gamble, Amanda L., et al.
Publicado: (2014)

Diabetes and Technology for Increased Activity Study: The Effects of Exercise and Technology on Heart Rate Variability and Metabolic Syndrome Risk Factors
por: Stuckey, Melanie I., et al.
Publicado: (2013)

Does Hypoxia Decrease the Metabolic Rate?
por: Gu, Chenjuan, et al.
Publicado: (2018)

Assessing Sleep Disturbance in Low Back Pain: The Validity of Portable Instruments
por: Alsaadi, Saad M., et al.
Publicado: (2014)

Association Between Diabetic Retinopathy and Insomnia Risk: A Nationwide Population-Based Study
por: Um, Yoo Hyun, et al.
Publicado: (2022)

Marrow adipose tissue is increased in overweight and obese women with PCOS independently of hyperandrogenism related obesity and metabolic disorders
por: Xu, Li, et al.
Publicado: (2023)

Pleiotrophin and metabolic disorders: insights into its role in metabolism
por: Ballesteros-Pla, Cristina, et al.
Publicado: (2023)

Associations Between C-Reactive Protein, Insulin Sensitivity, and Resting Metabolic Rate in Adults: A Mediator Analysis
por: Drabsch, Theresa, et al.
Publicado: (2018)

Musculoskeletal disorders increases the insomnia severity in nurses
por: Cici, Remziye, et al.
Publicado: (2022)

Metabolic Disorders and Male Hypogonadotropic Hypogonadism
por: Pivonello, Rosario, et al.
Publicado: (2019)

Editorial: Environmental exposomics and metabolic disorders
por: Paulesu, Luana Ricci, et al.
Publicado: (2023)

Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders
por: Choe, Sung Sik, et al.
Publicado: (2016)

P066 A randomised, double-blind, placebo-controlled, single-dose, crossover, pilot study investigating the effects of cannabinol (CBN) 30 mg and 300 mg on sleep architecture and next-day function in insomnia disorder
por: Lavender, I, et al.
Publicado: (2022)

Heart rate variability during slow wave sleep is linked to functional connectivity in the central autonomic network
por: Kong, Shawn D X, et al.
Publicado: (2023)

ANGPTL8: An Important Regulator in Metabolic Disorders
por: Luo, Mengdie, et al.
Publicado: (2018)

IL-33 at the Crossroads of Metabolic Disorders and Immunity
por: Tu, Lei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ntqt8vs63lq1m4it614jt095b9